1-1 of 1 results for subject:Pfizer
Librarians' tools
- Search time
- 0.176 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Business, Energy and Industrial Strategy, how many of the covid-19 vaccines that are under development the Government has ordered in addition to the Pfizer vaccine; and what estimate his Department has made of how many of each type of those vaccines the devolved...
To ask the Secretary of State for Business, Energy and Industrial Strategy, how many of the covid-19 vaccines that are under development the Government has ordered in addition to the Pfizer vaccine; and what estimate his Department has made of how many of each type of those vaccines the devolved...
The UK Government has secured early access to 355 million vaccines doses through agreements with seven separate vaccine developers, which have been purchased for the whole of the UK. This includes agreements with:
- BioNTech/Pfizer for 40 million doses;
- Oxford/AstraZeneca for 100 million doses;
- GlaxoSmithKline and Sanofi Pasteur for 60 million doses;
- Novavax for 60 million doses;
- Janssen for 30 million doses;
- Valneva for 60 million doses;
- Moderna for 5 million doses.